{
    "clinical_study": {
        "@rank": "97478", 
        "arm_group": {
            "arm_group_label": "misoprostol", 
            "arm_group_type": "Experimental", 
            "description": "400 mcg misoprostol sublingually"
        }, 
        "brief_summary": {
            "textblock": "Women presenting with incomplete abortion and eligible for treatment with misoprostol were\n      offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study\n      hypothesises that women can successfully be treated with misoprostol alone as first line\n      treatment."
        }, 
        "brief_title": "400mcg Sublingual Misoprostol as First Line Treatment", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Incomplete Abortion", 
        "condition_browse": {
            "mesh_term": "Abortion, Incomplete"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  uterine size less than 12 weeks lmp\n\n          -  open cervical os\n\n          -  current or past vaginal bleeding\n\n          -  willing to provide contact information for follow-up\n\n          -  over 18 or with guardian consent\n\n        Exclusion Criteria:\n\n          -  suspicion of ectopic pregnancy\n\n          -  intrauterine device in place\n\n          -  bad general health (infection, anemia, shoc)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "641", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01939457", 
            "org_study_id": "2.2.4"
        }, 
        "intervention": {
            "arm_group_label": "misoprostol", 
            "intervention_name": "Misoprostol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Misoprostol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guediawaye", 
                    "country": "Senegal"
                }, 
                "name": "Guediawaye Health Center"
            }
        }, 
        "location_countries": {
            "country": "Senegal"
        }, 
        "number_of_arms": "1", 
        "official_title": "Introduction of 400mcg Sublingual Misoprostol as First Line Treatment in 11 Health Posts in Three Districts in Senegal", 
        "overall_official": {
            "affiliation": "Gynuity Health Projects", 
            "last_name": "Beverly Winikoff, MD MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Senegal: Local Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "number of complete abortion with misoprostol treatment alone", 
            "measure": "complete abortion", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01939457"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Gynuity Health Projects", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gynuity Health Projects", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}